Cantor Fitzgerald initiated coverage on shares of LHC Group (NASDAQ:LHCG) in a research report sent to investors on Wednesday, Marketbeat Ratings reports. The firm issued an overweight rating and a $117.00 target price on the health services provider’s stock.

Several other equities research analysts also recently issued reports on LHCG. Zacks Investment Research upgraded shares of LHC Group from a hold rating to a buy rating and set a $96.00 price objective for the company in a research note on Thursday, June 21st. BidaskClub downgraded shares of LHC Group from a strong-buy rating to a buy rating in a research note on Tuesday, July 10th. ValuEngine upgraded shares of LHC Group from a hold rating to a buy rating in a research note on Saturday, June 2nd. Royal Bank of Canada boosted their price objective on shares of LHC Group to $101.00 and gave the stock a sector perform rating in a research note on Friday, August 3rd. Finally, Jefferies Financial Group boosted their price objective on shares of LHC Group to $120.00 and gave the stock a buy rating in a research note on Friday, August 3rd. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. LHC Group has an average rating of Buy and a consensus target price of $100.20.

LHC Group stock opened at $96.60 on Wednesday. LHC Group has a 1 year low of $58.65 and a 1 year high of $100.90. The company has a market capitalization of $2.98 billion, a P/E ratio of 34.84, a P/E/G ratio of 1.49 and a beta of 0.52. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.18.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, August 1st. The health services provider reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.06. LHC Group had a net margin of 3.75% and a return on equity of 8.33%. The company had revenue of $502.00 million during the quarter, compared to the consensus estimate of $509.03 million. During the same period in the previous year, the firm earned $0.63 earnings per share. LHC Group’s revenue for the quarter was up 95.0% on a year-over-year basis. research analysts predict that LHC Group will post 3.52 earnings per share for the current year.

In other news, COO Donald Dwayne Stelly sold 2,756 shares of the business’s stock in a transaction on Friday, September 7th. The shares were sold at an average price of $99.32, for a total transaction of $273,725.92. Following the transaction, the chief operating officer now directly owns 104,512 shares of the company’s stock, valued at $10,380,131.84. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Jeff Reibel sold 1,921 shares of the business’s stock in a transaction on Monday, August 20th. The stock was sold at an average price of $94.12, for a total transaction of $180,804.52. Following the transaction, the senior vice president now directly owns 8,125 shares in the company, valued at $764,725. The disclosure for this sale can be found here. Insiders own 6.80% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. lifted its position in shares of LHC Group by 76.9% during the second quarter. BlackRock Inc. now owns 4,619,436 shares of the health services provider’s stock worth $395,377,000 after purchasing an additional 2,008,433 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of LHC Group by 74.6% during the second quarter. Dimensional Fund Advisors LP now owns 2,133,200 shares of the health services provider’s stock worth $182,581,000 after purchasing an additional 911,625 shares in the last quarter. FMR LLC lifted its position in shares of LHC Group by 297.8% during the second quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock worth $98,548,000 after purchasing an additional 861,952 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of LHC Group by 162.0% during the second quarter. Bank of New York Mellon Corp now owns 711,508 shares of the health services provider’s stock worth $60,897,000 after purchasing an additional 439,947 shares in the last quarter. Finally, Royal Bank of Canada lifted its position in shares of LHC Group by 39.6% during the first quarter. Royal Bank of Canada now owns 615,249 shares of the health services provider’s stock worth $37,875,000 after purchasing an additional 174,480 shares in the last quarter. 87.05% of the stock is currently owned by institutional investors and hedge funds.

LHC Group Company Profile

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Read More: Fundamental Analysis

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.